Gut microbiota markers associated with obesity and overweight in Italian adults.
Palmas V, Pisanu S, Madau V, Casula E, Deledda A, Cusano R, Uva P, Vascellari S, Loviselli A, Manzin A, Velluzzi F. · 2021
Read Gut microbiota markers associated with obesity and overweight in Italian adults. by Palmas V, Pisanu S, Madau V, Casula E, Deledda A, Cusano R, Uva P, Vascellari S, Loviselli A, Manzin A, Velluzzi F. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7943584.txt.
Introduction
Palmas and co-authors report a study of gut microbes linked to obesity and overweight in Italian adults. The gut community differs between people of different weights. The team looked for the exact bacterial markers of that split. Their subjects came from Sardinia, which narrows the genetic and dietary background. Cases and controls were matched for sex, age, and smoking.
Stool DNA from 46 patients with obesity was compared with that of 46 normal-weight controls. The obesity group carried far fewer of several Bacteroidetes groups. Many Firmicutes groups ran higher instead. Body fat and waist size tracked those shifts in a clear pattern. Families known for endotoxin activity also ran higher in the obesity group. The results add named taxa to the map of the obese gut. They may guide later work on diet and treatment in this population.
Catalog record
| CREATOR | Palmas V, Pisanu S, Madau V, Casula E, Deledda A, Cusano R, Uva P, Vascellari S, Loviselli A, Manzin A, Velluzzi F. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Gut microbiota markers associated with obesity and overweight in Italian adults By Vanessa Palmas, Silvia Pisanu, Veronica Madau, Emanuela Casula, Andrea Deledda, Roberto Cusano, Paolo Uva, Sarah Vascellari, Andrea Loviselli, Aldo Manzin, Fernanda Velluzzi Published in: Scientific Reports DOI: 10.1038/s41598-021-84928-w ABSTRACT Abstract In the present study, we characterized the distinctive signatures of the gut microbiota (GM) from overweight/obese patients (OB), and normal-weight controls (NW), both of Sardinian origin. Fecal bacterial composition of 46 OB patients (BMI = 36.6 ± 6.0; F/M = 40/6) was analyzed and compared to that of 46 NW subjects (BMI = 21.6 ± 2.1; F/M = 41/5), matched for sex, age and smoking status, by using 16S rRNA gene sequencing on MiSeq Illumina platform. The gut microbial community of OB patients exhibited a significant decrease in the relative abundance of several Bacteroidetes taxa (i.e. Flavobacteriaceae, Porphyromonadaceae, Sphingobacteriaceae, Flavobacterium, Rikenella spp., Pedobacter spp., Parabacteroides spp., Bacteroides spp.) when compared to NW; instead, several Firmicutes taxa were significantly increased in the same subjects (Lachnospiraceae, Gemellaceae, Paenibacillaceae, Streptococcaceae, Thermicanaceae, Gemella, Mitsuokella, Streptococcus, Acidaminococcus spp., Eubacterium spp., Ruminococcus spp., Megamonas spp., Streptococcus, Thermicanus, Megasphaera spp. and Veillonella spp.). Correlation analysis indicated that body fatness and waist circumference negatively correlated with Bacteroidetes taxa, while Firmicutes taxa positively correlated with body fat and negatively with muscle mass and/or physical activity level. Furthermore, the relative abundance of several bacterial taxa belonging to Enterobacteriaceae family, known to exhibit endotoxic activity, was increased in the OB group compared to NW. The results extend our knowledge on the GM profiles in Italian OB, identifying novel taxa linking obesity and intestine. Subject terms: Microbiology, Microbial communities, Microbiome INTRODUCTION Obesity is one of the major health problems in the world due to the rapid increase in its prevalence and the emergence of metabolic co-morbidities observed since the mid-twentieth century. In Italy, in 2017 more than a third of the population (35.4%) aged 18 and over was overweight, while a little more than one in ten (10.5%) was obese. In line with these findings, the prevalence of obesity in Sardinia has more than tripled in the last 30 years1,2. Defined as a chronic disease, obesity is associated with increased mortality and represents a risk factor for the development of various diseases, including cardiovascular diseases, type 2 diabetes mellitus (T2DM), musculoskeletal disorders, various form of cancer, asthma, pulmonary embolism, gallbladder disease and metabolic syndrome3–5. The multifactorial etiology of obesity includes genetic, behavioral, socioeconomic, and environmental components6; however, the putative role of the gut microbiota (GM) disfunction (dysbiosis) in the pathogenesis of the disease has recently emerged. The GM is the community of microorganisms (bacteria, archaea, viruses, eukaryotes) colonizing the digestive tract7, and its alterations has been linked aside from functional gastrointestinal disorders, to obesity and other metabolic disorders, including T2DM and non-alcoholic fatty liver disease (NAFLD); furthermore, it could contribute to the development of metabolic syndrome (MS)5,8. Several mechanisms have been proposed to explain the potential role of GM in obesity development. Among them, the fermentation of non-digestible dietary polysaccharides by intestinal bacteria, resulting in the production of short-chain fatty acids (SCFAs), which can induce lipogenesis in the liver and triglycerides accumulation in host adipocytes. In addition, the GM can trigger a chronic low-grade inflammation (metabolic endotoxemia), due to the systemic translocation of the Gram-negative bacteria lipopolysaccharides (LPS)9,10. Metabolic endotoxemia, as well as lower microbial diversity, are presumed to be linked to the etiology of MS and its consequences5. The latter is a cluster of conditions including abdominal obesity, hyperglycemia, hypertension, insulin resistance, and dyslipidemia, whose link with GM composition has been confirmed by animal and human studies11. However, regarding the association between specific bacterial taxa and these pathological processes, only a few studies have examined the GM composition in the obese Italian adult population12–14, and few data are available regarding patients with MS15. This makes further scientific investigations necessary in order to identify a microbial pattern associated with metabolic diseases. The identification of microbial composition is, indeed, a first and relevant step towards the development of strategies for early diagnosis, monitoring of disease progression and its treatment. In the present study, our focus was to characterize the distinctive signatures of the GM from overweight/obese patients of Sardinian origin, compared to healthy controls; in addition, to verify, within the obese cohort, the extent of gut dysbiosis in patients with MS. RESULTS Subjects Clinical characteristics of the study groups are shown in Table 1. Remarkably, the fraction of women was prevalent in each study cohort, but no statistically significant differences were observed in terms of age and gender. Overall, the analysis of clinical data showed that the OB group diverged significantly from healthy controls in terms of BMI, waist circumference and various lifestyle factors. As regard to lifestyle data, the nutritional anamnesis highlighted in patients an excessive consumption of sugary drinks, sweets, industrial food, and a low consumption of fruit, vegetables, and pulses, as well as the absence of whole grains. In line with these findings, the analysis of the food diaries pointed out an excess of simple carbohydrates, of total lipids and saturated fatty acids and a lack of fibers intake; on the other hand, control subjects followed, as expected, a healthier diet, in terms of macronutrients quality, and caloric and fiber intake, which were more in line with National Recommended Energy and Nutrient Intake Levels (LARN) guidelines16. Noteworthy, patients had an excessive intake of saturated lipids (38% of the total lipid intake for OB), significantly greater than that of NW (27.8% of the total lipid intake) and, contrariwise, a low daily intake of fiber (15 g/day), significantly lower than that of NW (20.0 g/day). The Mediterranean Diet Score (MedDietScore) highlighted good compliance to Mediterranean Diet (MD) in NW (33.4 ± 4.1), while it was lower in OB (28 ± 5), although this difference was not statistically significant (p = 0.106). The level of physical activity was low in the group of patients and significantly reduced compared to NW, who, in contrast, engaged in a medium–high level of physical activity. By stratifying the OB group for the presence of metabolic syndrome, the anthropometric and lifestyle data of overweight and obese patients with MS (OMS) and without MS (OWMS) almost reflected those of non-stratified OB; on the other hand, no statistically difference was observed between OMS and OWMS for each clinical and metabolic alterations, except, as expected, for the prevalence of cardiometabolic risk factors (dyslipidemia, alteration in glucose metabolism and hypertension) (see Supplementary Table S1 online). [Table: Clinical characteristics of study participants.] GUT MICROBIOTA ANALYSIS Alpha and beta diversity analysis The richness and diversity of the microbial community (alpha diversity) in OB was lower than that in NW, albeit no significant difference in the Shannon index was observed (OB = 2.299 ± 0.338, NW = 2.334 ± 0.175, p = 0.833). Similarly, no statistically significant differences in the Shannon index across different BMI categories and between metabolic syndrome discordant obese patient subgroups were observed (p = 0.780 and 0.873, respectively) (see Supplementary Tables S2, S3, S4 online). The Principal Coordinates Analysis (PCoA) based on Bray–Curtis distance matrix showed a marked separation between the GM communities of OB and NW (see Fig. 1), confirmed by PERMANOVA analysis, adjusted for sex, age and